News

Precision Biologics, Inc. CEO to present at the online Antibody-Drug Conjugates MicroSummit conference, March 17th, 2026.

Strattmont Group2026-03-12T14:47:23-04:00

Philip M. Arlen, M.D., will present an online talk at the third and last session...

Precision Biologics featured in Pharma Device News article March 8, 2026

Strattmont Group2026-03-12T13:19:53-04:00

Precision Biologics' approach is the subject of an article in the current issue of trade...

Precision Biologics, Inc. CEO Philip M. Arlen, MD, to give presentation on monoclonal antibodies against tumor-specific targets at Festival of Biologics USA, San Diego Convention Center, San Diego, CA, March 4-5, 2026

Strattmont Group2026-03-02T14:01:34-05:00

Precision Biologics, Inc. CEO Philip M. Arlen, MD, will give a presentation on monoclonal antibodies...

Dr. Philip M Arlen to present Keynote at the 6th Ace Drug Discovery Summit, London, UK, February 19, 2026

Strattmont Group2026-02-17T18:44:05-05:00

Precision Biologics, Inc. CEO Philip M Arlen, MD will give a Keynote speech and present...

Precision Biologics to Reveal Preclinical Efficacy of Novel Tumor-Specific ADC against multiple human cancer types at SITC 2025

Strattmont Group2025-12-10T10:26:39-05:00

BETHESDA, Md., Nov. 5, 2025 /PRNewswire/ -- Precision Biologics, Inc. announces in vitro and in vivo efficacy of its novel...

Precision Biologics to present data on new antibody-drug conjugate PB-223 ADC at AACR, Chicago, IL, April 25 – 30, 2025

Strattmont Group2025-04-25T11:50:42-04:00

Precision Biologics, Inc. will present new data on a newly developed Antibody-Drug Conjugate PB-223 ADC...

Dr. Philip M Arlen to present at Festival of Biologics USA, San Diego, CA, April 23 – 24, 2025

Strattmont Group2025-04-23T16:16:05-04:00

Precision Biologics, Inc. CEO Philip M Arlen, MD will give the Keynote speech, and also...

Precision Biologics highlighted in GEN article, April 2025 issue

Strattmont Group2025-04-18T12:15:32-04:00

An article titled “Cancer Vaccines-Improving Their Aim” in the current April 2025 issue of trade...

Precision Biologics, Inc. to present at Antibody Therapeutics Xchange, April 15th, 2025, Philadelphia, PA

Strattmont Group2025-03-07T13:36:58-05:00

Precision Biologics announces that our Chief Scientific Officer, Kwong "Al" Tsang, will deliver a talk...

Precision Biologics, Inc. to present at AACR IO 2025, February 24, 2025, Los Angeles, CA

Strattmont Group2025-02-24T14:20:16-05:00

Precision Biologics announces that our Director of Research & Development, Massimo Fantini, PhD, will deliver...